← Back to Search

Virus Vaccine

MODERNA SARS-CoV-2 Vaccine for Chronic Kidney Disease (BOOST KIDNEY Trial)

Phase 2 & 3
Waitlist Available
Research Sponsored by Sunnybrook Health Sciences Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

BOOST KIDNEY Trial Summary

This trial is being done to see if MODERNA or Pfizer-BioNTech COVID-19 vaccine is better in boosting immunity in chronic kidney disease and dialysis patients.

Eligible Conditions
  • Chronic Kidney Disease
  • COVID-19
  • Coronavirus

BOOST KIDNEY Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one month
This trial's timeline: 3 weeks for screening, Varies for treatment, and one month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Serum Level of Anti-RBD ( Anti Receptor Binding Domain )
Secondary outcome measures
Adverse Event
Death
Hospitalization
+3 more

BOOST KIDNEY Trial Design

4Treatment groups
Experimental Treatment
Group I: Patients who received two doses Pfizer-BioNTech vaccine, Arm 1Experimental Treatment1 Intervention
Group II: Patients who received two doses Pfizer-BioNTech vaccine ,Arm 3Experimental Treatment1 Intervention
Group III: Patients who received two doses MODERNA vaccine, Arm 4Experimental Treatment1 Intervention
Group IV: Patients who received two doses MODERNA vaccine, Arm 2Experimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pfizer-BioNTech COVID-19 Vaccine
2021
Completed Phase 2
~750

Find a Location

Who is running the clinical trial?

University Health Network, TorontoOTHER
1,465 Previous Clinical Trials
483,421 Total Patients Enrolled
Sunnybrook Health Sciences CentreLead Sponsor
655 Previous Clinical Trials
1,549,978 Total Patients Enrolled
Unity Health TorontoOTHER
535 Previous Clinical Trials
446,811 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What other research has been done on the MODERNA SARS-CoV-2 Vaccine?

"As of today, there are a total of 56 active trials for the MODERNA SARS-CoV-2 Vaccine. Out of these, 19 are currently in Phase 3. Additionally, while several studies originate from Liverpool and New york, there are 1,317 total locations running trials for this vaccine globally."

Answered by AI

Are we looking for more participants in this trial?

"The clinical trial in question is no longer recruiting patients, as indicated on the website clinicaltrials.gov. This page was originally created on September 30th, 2021 and last updated on August 5th, 2022. There are 1694 other trials that are currently enrolling participants."

Answered by AI

How many people are currently signed up for this research project?

"Unfortunately, this particular trial is no longer admitting patients. The study was first made public on September 30th 2021 and the most recent update was on August 5th 2022. There are presently 1638 other studies that are still enrolling patients with covid-19 and 56 for the MODERNA SARS-CoV-2 Vaccine."

Answered by AI

Have patients undergone this treatment before?

"There are currently 56 ongoing clinical studies for the MODERNA SARS-CoV-2 Vaccine across 332 cities and 38 countries. The first study began in 2020 and involved 120 patients. It completed its Phase 1 drug approval stage successfully. Since then, 27 other studies have been completed."

Answered by AI

Who else is applying?

What state do they live in?
California
North Carolina
Virginia
Other
How old are they?
18 - 65
What site did they apply to?
University Health Network
What portion of applicants met pre-screening criteria?
Met criteria
~77 spots leftby Apr 2025